RavenQuest BioMed CEO Outlines Progress in Exclusive CFN Interview


Ryan Allway

May 9th, 2018

Exclusive, News, Top News


Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis nationwide. While there are over 100 licensed producers planning to have over 700,000 kilograms of production capacity online by the end of the year, Marijuana Policy Group estimates that demand could exceed 900,000 kilograms and there could be a shortfall in supply.

Investors looking to capitalize on these supply and demand economics have many options, but the best opportunities are companies with strong management teams focused on a niche market that won’t be eroded by the commoditization of the industry over time.

RavenQuest BioMed Inc. (CSE: RQB) began as a management and consulting firm that helped nearly 60 clients become licensed producers of medical cannabis under Health Canada’s ACMPR program. After taking the time to understand their problems, the company partnered with McGill University and began researching technology solutions and began pursuing partnerships that leverage its public company status to finance projects.

CFN Media recently sat down with CEO George Robinson to discuss the company’s approach to the market and why investors may want to take note:

 

Four Pillar Approach

RavenQuest BioMed’s experience helping companies become licensed producers helped form the four pillar approach that guides its current business. The company began by looking at some of the Good Manufacturing Processes, or GMP, issues facing their consulting clients. From there, they started asking if they could help out with the cultivation side of the business. Breaking down these problems led to the realization that many clients wanted bundled solutions.

CEO George Robinson outlines these four pillars as questions in the interview:

  • How could we be a company that consulted to generate immediate revenue?
  • How could we work with companies from a targeted acquisition standpoint?
  • How could we work using our unique approach to R&D with McGill University to understand how to grow better and use growing technologies better?
  • How do we take this whole approach and bring it to the indigenous people?

From an investor standpoint, the four pillar approach is unique in that it generates near-term revenue through consulting agreements and builds long-term value through research and development with an industry-leading institution. Management’s approach of working with indigenous peoples also translates to a unique niche market that is actively seeking turnkey solutions to produce and sell cannabis on sovereign land.

Advancing Its Projects

RavenQuest BioMed’s MOU with Fort McMurray #468 to develop, operate, and finance a purpose-built facility for the production of cannabis marks a key turning point. Under the terms of the agreement, the company will receive a 30 percent ownership stake in the 24,000 sq. ft. facility, which will be rapidly expanded to a maximum of 250,000 sq. ft. The facility could produce upwards of 50,000 kilograms per year, netting the company 15,000 kilograms per year.

At the same time, the company announced an MOU to acquire  late-stage ACMPR applicant, Western AgriPharm Ltd., which has a 125,000 sq. ft. grow space in development. The company also signed a lease for space in downtown Edmonton, where it aims to open its first retail recreational cannabis store. The retail space is strategically located near the city’s downtown area and features a unique retail experience dedicated to education and awareness.

In addition to proving out the four pillar approach, these projects could become a valuable proof-of-concept for future indigenous peoples partnerships and other consulting arrangements. Under its indigenous programs, the company would provide sovereign nations with its technical know-how, staff resources, and financing opportunities in exchange for a percentage ownership in the facilities and potential production through offtake agreements.

The company and its shareholders benefit from steady recurring revenue that’s tied to the production and sale of cannabis without the risks associated with growing. At the same time, the company could be working with multiple indigenous peoples groups, which provides an added level of diversification for shareholders. These attributes could translate to higher risk-adjusted returns than investing in traditional licensed producers.

Looking Ahead

RavenQuest BioMed Inc. (CSE: RQB) represents a compelling investment opportunity in Canada’s cannabis industry. In addition to generating near-term consulting revenue, the company’s MOU with Fort McMurray #468 paves the way to revenue from the cultivation and sale of cannabis. Meanwhile, management’s partnership with McGill University is looking at technologies that could fill out a valuable intellectual property portfolio.

Investors looking for diversified exposure to Canada’s rapidly growing cannabis industry may want to take a closer look at the stock. For more information, visit the company’s website or download their investor presentation.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://www.cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading